Tobam raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 15.3% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,695 shares of the healthcare conglomerate’s stock after acquiring an additional 358 shares during the period. Tobam’s holdings in UnitedHealth Group were worth $1,412,000 as of its most recent SEC filing.
Several other hedge funds have also recently added to or reduced their stakes in UNH. Capital & Planning LLC raised its stake in UnitedHealth Group by 19.2% during the 4th quarter. Capital & Planning LLC now owns 491 shares of the healthcare conglomerate’s stock valued at $248,000 after acquiring an additional 79 shares in the last quarter. Brighton Jones LLC raised its stake in shares of UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after buying an additional 28,231 shares in the last quarter. Union Bancaire Privee UBP SA bought a new stake in shares of UnitedHealth Group in the 4th quarter worth $27,233,000. Revolve Wealth Partners LLC raised its stake in shares of UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after buying an additional 2,324 shares in the last quarter. Finally, Van ECK Associates Corp raised its stake in shares of UnitedHealth Group by 12.6% in the 4th quarter. Van ECK Associates Corp now owns 196,907 shares of the healthcare conglomerate’s stock worth $99,607,000 after buying an additional 22,059 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.
Insiders Place Their Bets
In related news, CFO John F. Rex purchased 17,175 shares of UnitedHealth Group stock in a transaction on Friday, May 16th. The stock was bought at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the completion of the transaction, the chief financial officer now directly owns 203,796 shares of the company’s stock, valued at approximately $59,329,091.52. This represents a 9.20% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Stephen J. Hemsley acquired 86,700 shares of the business’s stock in a transaction that occurred on Friday, May 16th. The shares were acquired at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the transaction, the chief executive officer now directly owns 679,493 shares in the company, valued at $196,081,295.01. The trade was a 14.63% increase in their position. The disclosure for this purchase can be found here. Insiders purchased 109,408 shares of company stock valued at $31,607,768 over the last quarter. Insiders own 0.28% of the company’s stock.
UnitedHealth Group Price Performance
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period in the previous year, the business posted $6.91 EPS. Analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be given a $2.21 dividend. The ex-dividend date of this dividend is Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.78%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s payout ratio is currently 37.02%.
Wall Street Analysts Forecast Growth
A number of research firms have recently commented on UNH. Mizuho dropped their price objective on UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating on the stock in a research note on Friday, May 16th. Wells Fargo & Company reissued an “overweight” rating on shares of UnitedHealth Group in a research note on Friday, June 6th. Hsbc Global Res cut UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a report on Wednesday, May 21st. TD Cowen cut UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 target price on the stock. in a report on Monday, May 19th. Finally, Truist Financial restated a “buy” rating and issued a $360.00 target price (down from $580.00) on shares of UnitedHealth Group in a report on Monday, May 19th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $426.52.
Read Our Latest Stock Report on UnitedHealth Group
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
- Five stocks we like better than UnitedHealth Group
- Airline Stocks – Top Airline Stocks to Buy Now
- Ignore the Noise—Samsara Stock Is Still a Strong Buy
- What is the Nasdaq? Complete Overview with History
- 3 Stocks Set to Double—And There’s Still Time to Buy
- Stock Analyst Ratings and Canadian Analyst Ratings
- Analysts Can’t Get Enough of These Little-Known Biopharma Stocks
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.